| Total Revenue (Q3) | $980 million | CEO – exceeded guidance |
| Adjusted EBITDA (Q3) | $196 million | CEO – exceeded guidance |
| Adjusted EPS (Q3) | $2.37 | CEO – exceeded guidance; includes $0.15 stock comp benefit (CFO) |
| Operating Cash Flow (Q3) | >$176 million | CFO – up 12.5% YoY |
| Free Cash Flow (Q3) | >$156 million | CFO |
| Leverage Ratio (Q3 end) | 2.3x | CFO – per credit agreement |
| Share Repurchase (YTD 2025) | $500 million, 3.5M shares at $144.55 avg | CFO – reduced share count by 6.4% |
| Noncash Impairment (Resi, Q3) | $709 million | CEO – accounting-driven valuation adjustment |